FDA Approvals (July 2024 – January 2025): Advancements in Cardiorenal and Cardiometabolic HealthÂ
Get the latest FDA-approved drugs and devices for cardiometabolic and cardiorenal conditions and risk factors. Explore now!
FDA Approves First Year-Long Continuous Glucose Monitoring Sensor for Diabetes
Discover the impact of this breaking FDA approval of the first year-long Continuous Glucose Monitoring sensor—READ NOW!
